275 related articles for article (PubMed ID: 30733585)
1. Objective risk stratification of prostate cancer using machine learning and radiomics applied to multiparametric magnetic resonance images.
Varghese B; Chen F; Hwang D; Palmer SL; De Castro Abreu AL; Ukimura O; Aron M; Aron M; Gill I; Duddalwar V; Pandey G
Sci Rep; 2019 Feb; 9(1):1570. PubMed ID: 30733585
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
3. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
[TBL] [Abstract][Full Text] [Related]
4. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.
Wildeboer RR; Mannaerts CK; van Sloun RJG; Budäus L; Tilki D; Wijkstra H; Salomon G; Mischi M
Eur Radiol; 2020 Feb; 30(2):806-815. PubMed ID: 31602512
[TBL] [Abstract][Full Text] [Related]
5. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
[TBL] [Abstract][Full Text] [Related]
7. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Wang XN; Zhang YD
Eur Radiol; 2017 Oct; 27(10):4082-4090. PubMed ID: 28374077
[TBL] [Abstract][Full Text] [Related]
8. PI-RADS and Likert scales for structured reporting in multiparametric MR imaging of the prostate.
Desai S; Costa DN
Br J Radiol; 2022 Mar; 95(1131):20210758. PubMed ID: 34586917
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
11. A dynamic-static combination model based on radiomics features for prostate cancer using multiparametric MRI.
Li S; Zheng T; Fan Z; Qu H; Wang J; Bi J; Lv Q; Zhang G; Cui X; Zhao Y
Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36541844
[No Abstract] [Full Text] [Related]
12. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
13. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI.
Khanfari H; Mehranfar S; Cheki M; Mohammadi Sadr M; Moniri S; Heydarheydari S; Rezaeijo SM
BMC Med Imaging; 2023 Nov; 23(1):195. PubMed ID: 37993801
[TBL] [Abstract][Full Text] [Related]
14. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
16. Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.
Toivonen J; Montoya Perez I; Movahedi P; Merisaari H; Pesola M; Taimen P; Boström PJ; Pohjankukka J; Kiviniemi A; Pahikkala T; Aronen HJ; Jambor I
PLoS One; 2019; 14(7):e0217702. PubMed ID: 31283771
[TBL] [Abstract][Full Text] [Related]
17. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
[TBL] [Abstract][Full Text] [Related]
18. Repeatability of Multiparametric Prostate MRI Radiomics Features.
Schwier M; van Griethuysen J; Vangel MG; Pieper S; Peled S; Tempany C; Aerts HJWL; Kikinis R; Fennessy FM; Fedorov A
Sci Rep; 2019 Jul; 9(1):9441. PubMed ID: 31263116
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
[TBL] [Abstract][Full Text] [Related]
20. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
